BLOODSTREAM INFECTIONS IN INTENSIVE CARE UNIT PATIENTS

IN TERTIARY HOSPITALS IN SANA’A CITY, YEMEN

Eshtiaq A  Al-Yousafi1 ,  Hassan Abdulwahab Al-Shamahy2 , Arwa Mohammed Othman3 , Abdul-Al-Raoof Mohammad AlShawkany3 

1Medical Microbiology and Clinical Immunology Department, Faculty of Medicine and Health Sciences, Sana’a University.

        2Medical Microbiology department, Faculty of Medicine, Genius University for Sciences and  Technology, Dhamar city,

Republic of Yemen.

3Molecular Genetics Department, College of Veterinary Medicine, Sana`a University, Yemen.

ABSTRACT 

Background and Aims:  One of the most common infection among critically ill patients is bloodstream infection (BSI). The present study was conducted to inspect the clinical manifestations, and septic organisms in the intensive care units of university hospitals in Sana'a city, Yemen. Also to compare clinical characteristics, mortality and risk factors for positive case versus negative case for bacterial growth among sepsis patients.

Subjects and methods: From January 1 to April 30, 2022, a cross-sectional study was undertaken on sepsis patients hospitalized in intensive care units at four hospitals in Sana'a, Yemen. A well-structured questionnaire was used to collect specific medical data for each subject. Patients suspected of having sepsis underwent tests such as blood culture, complete blood count, and C-reactive protein. Gram staining was used to identify organisms, and the VITEK II Bacterial Bioprinting System was used to study them. This study included 145 intensive care unit (ICU) patients who displayed one or more indications of sepsis.

Results: Of the 145 ICU patients with suspected sepsis, 87 (60%) had culture-confirmed sepsis. The bulk of the identified bacteria (57.5%) were Gram-negative. In the ICU, the most prevalent sepsis agents are E. coli (23%), Klebsiella species (12.6%), and Burkholderia cepacia (7%). The most common Gram-positive pathogens are Staphylococcus epidermidis (27.6%) and S. aureus (10.3%). Significant positive culture outcomes were found with rapid onset of sepsis (OR=3.3, p=0.002), decreased urination (OR=2.2, p=0.02), older patients (OR=4, p=0.001), and death (OR=7.8). The commonest symptoms among the cases were  fever (66.9%), increased heart rate (67.6%), confusion (62.8%) and respiratory distress (52.4%); the mortality rate was 29%.

Conclusion: Gram-negative bacteria were the most common cause of sepsis, and substantial positive culture results were associated with early onset, decreased urination, older patients, and death. Sepsis's incidence, mortality, and morbidity rates in Yemen are likely underestimated because it is infrequently reported as a primary diagnosis (typically as a consequence of cancer or another illness). More research into the frequency and risk factors of sepsis in ICUs is recommended.

 Keywords: Bacteria, blood culture, Bloodstream infections (BSIs), Gram-negative, Gram positive, ICUs, Sepsis. 

INTRODUCTION

Bloodstream infections (BSIs) are among the most common acquired illnesses in intensive care unit (ICU) patients. BSIs might be the result of bacterial bloodstream diffusion from a localized illness (secondary BSI) or the only recognized infectious process (primary BSI)1. In a global assessment evaluating the occurrence and consequences of infections in intensive care units, BSIs were found in 15% of infected patients and were the 3rd most generally seen illness1.  In view of the developing health-care-system organization, the established categorization of BSIs as community-acquired or hospital-acquired is being revisited. An increasing percentage of patients with advanced age and many co-morbidities are care for as outpatients, since health care services are shifting from hospitals to the community via various out-of-hospital institutions2,3. The severity of the disease, the disruption of anatomical barriers (i.e., use of invasive equipment and surgery), and compromised immune response are just a few of the risk factors for developing BSI in patients in critical care units4. Additional risk factors for catheter-related BSIs in patients with central venous catheters (CVC) include insufficient sterile method adoption, operator inexperience, insertion site colonization, contamination of the catheter hub, and duration of catheter installation5-7. Risk factors for BSIs brought on by resistant bacteria have been identified in a number of observational studies8. The risk of BSI brought on by resistant microbes is generally enhanced by prior antibiotic exposure, hospitalization, stays in nursing homes and long-term care institutions, and other risk factors for healthcare-associated BSI9,10. Additionally, being extremely young or old, having a weaker immune system as a result of diseases like cancer or diabetes, serious trauma, and burns are risk factors for ICU sepses11-14. Numerous species, including bacteria, viruses, and fungi, can result in sepsis11.  The lungs, brain, urinary tract, skin, and abdominal organs are typical sites for the main infection12. A recently published multinational observational research13 of 1,156 ICU patients worldwide revealed data on hospital-acquired BSIs.  Gram-positive microbes made up 33.4% of all BSI-causing pathogens, whereas Gram-negative ones made up 56.8%. Although sepsis guidelines advise getting blood cultures before beginning antibiotic treatment, infection in the blood is not necessary for the diagnosis. Finding the potential site of the infection can be aided by medical imaging. Similar signs and symptoms could also be caused by anaphylaxis, adrenal insufficiency, low blood volume, heart failure, and pulmonary embolism12.

This study was conducted to investigate the clinical manifestations, and septic organisms in intensive care units of university hospitals, Sana'a, Yemen. Also to compare clinical characteristics, mortality and risk factors for positive case versus negative case for bacterial growth among sepsis patients.

 

SUBJECTS AND METHODS 

 

Study design and subjects: In this cross-sectional study, ICU patients admitted to ICUs at Al Kuwait, Al Gumhory, Al Sabeen, and ALThawra hospitals in Sana'a city between initial admission and first January 1 through April 30 in 2022 (time allowed for PhD field work in clinical microbiology). During the study period, patients who had suspected sepsis and were admitted for at least 72 hours were included. 

Diagnosis of sepsis: According to international criteria, sepsis was suspected based on the presence of clinical indications or risk factors and was confirmed as sepsis if a blood culture was positive15.

Questionnaire: Face-to-face interviews with the patients' family were used to gather vital and socio-demographic information using self designed questionnaire. Clinicians used standardized instruments to capture the clinical characteristics of individuals with sepsis. All patients' guardians provided written consent after being informed of the study's objectives.

Ethic approval: The Research and Ethics Committee of the Faculty of Medicine and Health Sciences at Sana'a University, Sana'a, Yemen, approved all the methods used in this study (Approval No. UGR/SU-223).

Laboratory investigations

Standard microbiological procedures were followed when conducting laboratory examinations16. Trained nurses took blood samples under aseptic conditions that were used for laboratory tests on complete blood counts, C-reactive proteins, and blood cultures. Blood was inoculated into a BacT/Alert PF plus culture bottle (BIOMERIEUX, France, LOT 4053532) with at least 1 ml (usually 5 ml in adult patients) and allowed to incubate until the BacT/Alert instrument (BACTEC 9050, Becton Dickinson) flagged it as positive or negative for culture. All positive samples were sub-cultured on blood agar, MacConkey agar, and choclate agar, and they were all incubated at 37 °C for 24-48 hours. To distinguish between gram-positive and gram-negative bacteria, gram-staining was used. To suspend the bacterium in 3.0 ml of sterile saline in a test tube, enough pure culture colonies were employed. According to the instructions in the product information manuals (BIOMERIEUX), pure bacterial suspension was added to the bacterial specific identification and sensitivity testing kit device and analyzed by the VITEK II system for bacterial bio-typing and antibiotic susceptibility (results of patterns will be published in a separate article). Gram negative bacteria were identified using a VITEK ® GN ID identification card (lot 2410933203), while gram positive bacteria were identified using a VITEK ® GP ID identification card (lot 2420938203). All treatments were carried out for standard therapeutic and diagnostic purposes.

Statistical analysis: EPI-Info version 6.0 was used to analyze the data (CDC, USA). The frequencies of categorical variables were displayed. Using Pearson's chi-square, associations between independent and dependent variables were examined, and odds ratios (OR) and 95% confidence intervals (CI) were given. When necessary, Fisher's exact test was applied. A p value of 0.05 or less was regarded as significant.

 

RESULTS

 

The study is set out in 3 tables, and Table 1 shows the gender and ages of the sepsis patients, who were tested for bacterial septicemia. Male patients were 59.3% and female patients 40.7%, and 38.8% were children under 15 years of age, with a mean ± SD of total age equal to 34.3 ± 28.5 years, and ages ranged from 1 month to 90 years (Table 1). Of the 145 ICU patients with suspected sepsis, 87 (60%) had culture-confirmed sepsis. The bulk of the identified bacteria (57.5%) were Gram-negative. In the ICU, the most prevalent sepsis agents are E. coli (23%), Klebsiella species (12.6%), and Burkholderia cepacia (7%). The most common Gram-positive pathogens are Staphylococcus epidermidis (27.6%) and S. aureus (10.3%) (Table 2). Significant positive culture outcomes were found with rapid onset of sepsis (OR=3.3, p=0.002), decreased urination (OR=2.2, p=0.02), older patients (OR=4, p=0.001), and death (OR=7.8). The commonest symptoms among the cases were fever (66.9%), increased heart rate (67.6%), confusion (62.8%) and respiratory distress (52.4%); the mortality rate was 29% (Table 3). 

 

DISCUSSION

 

Sixty percent of the current patient sample had sepsis with a culture that was positive, which is comparable to the 40–70% range reported in the majority of other investigations17-21.  Additionally, the scope of the current investigation is greater than that of study of Sigakis et al.,22 where only 11% of samples were positive for cultures. This may be due to Sigakis et al., study22 involving patients from all hospital units rather than only the ICU, as was the case in the current analysis. Additionally, earlier studies used culture results from samples taken before presentations or prospectively over the course of more than 24 hours, and results may be influenced by infection from an earlier or later hospital stay. A feature of the current study that helps to better isolate the impact of a sepsis episode is the restriction of cultures to samples collected during the first 24 hours after fulfilling sepsis criteria.

When compared to the findings for neonatal sepsis, our study's culture-confirmed sepsis rate was high (60%). Studies from underdeveloped nations found varying percentages of culture-confirmed neonatal sepsis, including 62.8% in Pakistan23, 57% in Yemen24, 45.9% in Egypt25, 44.7% in Ethiopia26, 24% in Tanzania27, and 12.6% in Nepal28. The proportion of newborn with sepsis varies between nations for a number of reasons, including sample size and the various methods employed.A recent international observational research that included 1,156 ICU patients worldwide provided data on hospital-acquired BSIs13.  In the current investigation, 34.5% of the total number of BSI-causing bacteria were Gram-negative and 28.3% were Gram-positive. In the current study, 24 (16.6%) of all septicemia-related ICU patients had Coagulase-negative staphylococci (CoNS) (Table 2).  In newborns, coagulase-negative staphylococci (CoNS) are the most frequent bacteria responsible for late-onset sepsis. They frequently exhibit multiple forms of antibiotic resistance, and their capacity to produce biofilm is thought to be the primary factor determining their pathogenicity. A lower host inflammatory response was linked to CoNS sepsis with biofilm-forming strains, which may have limited the immune system's ability to fight the infection29.

S. aureus was implicated in septicemia in the present investigation in 9 (6.2%) of all septicemia ICU patients (Table 2).  S. aureus is a Gram-positive, facultative anaerobic pathogen that can be acquired in both hospitals and the community. It is a component of the skin's microbiota and is typically isolated from moist regions like the axillae and anterior nares30. Many S. aureus strains, which were once opportunistic, are now aggressively pathogenic and responsible for a wide spectrum of disorders, from skin and wound infections to serious conditions like BSIs and soft-tissue and bone infections30,31. S. pneumoniae was implicated in 5 (3.4%) of the total septicemia patients in the ICU in the current investigation (Table 2). Streptococcus pneumoniae can enter the bloodstream through a number of different routes, including lymphatic vessels, endothelium and epithelial cell injury, and direct invasion of endothelial cells. All three mechanisms most likely help infected patients' bloodstream invasion15. Twenty (13.8%) of the total number of septicemia ICU patients in the current study had E. coli septicemia (Table 2).  Most frequently commensal, E. coli are Gram-negative, facultative anaerobes that can produce potentially lethal toxins, including enterohemorrhagic verotoxins, such E. coli O157:H7, which can lead to hemolytic uremic syndrome and renal failure32. In the current study, 11 (7.6%) of all the ICU patients with septicemia were caused by Klebsiella pneumoniae (Table 2).  Despite being a rare sepsis-causing bacteria, Klebsiella pneumoniae is widely known for its severe consequences and high mortality. Due to a probable immune system decline, K. pneumoniae-caused bacteremia is more common and has a worse prognosis in patients with underlying illnesses. Therefore, it is crucial to control underlying illnesses to reduce the death rate from sepsis caused by K. pneumoniae33.

B. cepacia was the etiology of septicemia in the current investigation in 6 (4.1%) of all septicemia ICU patients (Table 2). B. cepacia (Bcc) is an aerobic, catalase-producing, Gram-negative bacillus that is normally of moderate virulence and is not thought to be a normal component of the human flora. It can have a serious impact on children who are immunocompromised, such as those who have cancer, congenital heart disease, or a history of prematurity. In children with cystic fibrosis (CF) and chronic granulomatous disease (CGD), significant bacteremia is seen in some cases. Immunocompetent people are rarely impacted, however nosocomial infections have been reported as a result of tainted drugs. Examples include ultrasound gel, contaminated sodium chloride, pure water, and 5% dextrose. 

The methods of transmission are nebulization, flushing orogastric tubes, and humidifying oxygen delivery equipment34. In the current study, Haemophilus influenzae caused septicemia in 5 (3.4%) of the total septicemia ICU patients (Table 2). Infections like bacteremia, meningitis, epiglottitis, and septic arthritis are brought on by Hi's profusion of virulence factors, which offer resistance to complement. Patients with neoplasm, asplenia, alcohol use disorder, HIV infection, chronic pulmonary disease, long-term steroid usage, or an underlying viral lung infection are more likely to contract the infection35.

Two (1.4%) of the total number of ICU patients with septicemia were affected by Enterobacter (Table 2). Enterobacter is a genus of Gram-negative, facultatively anaerobic, opportunistic infections that express a wide range of ESBLs and carbapenemases, including KPC, OXA, and MBLs36. This pathogen also has endotoxins36. In the current study, Acinetobacter baumannii was discriminated for septicemia in 4 (2.8%) of the total septicemia ICU patients (Table 2). Acinetobacter baumannii, a gram-negative, faculta-tively anaerobic, opportunistic pathogen, is the most prevalent resistant Acinetobacter species. It can survive for up to 5 months on inanimate things because of its thick cell wall, which helps it withstand dry circumstances, high temperatures, and changes in pH and nutrients37.  As a result of both limited membrane penetration and active efflux pumps, A. baumannii naturally resists a wide range of antibiotics. Widespread resistance to cephalosporins, fluoro-quinolones, aminoglycosides, and tigecycline is brought on by over-expression of the AdeABC and AbeM efflux pumps, which also confers resistance to ammonia-based disinfectants38. Additionally, A. baumannii isolates produce an exo-polysaccharide that causes the formation of biofilms and express a potent cytotoxin that specifically targets epithelial cells to aid in colonization39.  

P. aeruginosa was discriminated to septicemia in 3 (2.1%) of the total septicemia ICU patients (Table 2). P. aeruginosa is a facultative anaerobic, Gram-negative, rod-shaped, opportunistic bacteria  surviving in microaerobic states, for instance, the thick mucus of lungs of cystic fibrosis patients. The ubiquity and survival capacity of antimicrobial solutions of acetate-buffered benzalkonium chloride in extreme environments are major determinants of outbreaks of nosocomial infections. It has a high propensity to form biofilms. Its outer-membrane porins make it impermeable and resistant to many antibiotics40,41.  Chryseobacterium indologenes was discriminated for septicemia in 1 (0.7%) of the total septicemia ICU patients (Table 2). A Gram-negative, oxidase-positive, non-glucose-fermenting bacillus, C. indologenes is present in the environment. Human infections are typically related with devices, occur in patients who have undergone medical procedures, or in patients who have underlying medical disorders and are hospitalized, especially those who have taken broad-spectrum antibiotics42.

In the current study, patients in ICUs have different risk factors for BSI devel­opment, the most common risk factors were  diabetic mellitus (35.9%), younger age (33.8%), old age (33.1%) and kidney disorders (31.7%),  followed by major trauma (26.9%), asthma (18.6%) and burns (15.9%). However less frequently with myeloma, cancer, autoimmune disorder, immunocompromized and chronic obstructive pulmonary disease (Table 3). These results are similar to those reported by the CDC for risk factors of contracting septicemia among ICUs patients43. In another study conducted by Timsit  and  Laupland4; found that patients in ICUs have different risk factors for BSI devel­opment, including greater severity of illness, disruption of anatomical barriers (ie, use of invasive devices, or surgery), and impaired immunological response4.  Also several studies reported that patients with a central vein catheter (CVC) have additional risk factors for catheter-related BSIs (inadequate adoption of a sterile technique, inexperience of the operator, site of insertion, colonization of the insertion site, contamination of the catheter hub, and duration of catheter placement)5-7. When comparing a positive culture with a negative culture, considering clinical features, there was a high rate of positive culture with a rapid onset of sepsis symptoms  (77.6%) with an associated odds ratio of 3.3, confidence interval=1.5–7.2 p=0.002, while there

With regard to septicemia risk factors, there was a high proportion of positive cultures in older patients (64.6%), with an associated OR of 4, CI=1.1-9.9, and p=0.001 (Table 3). Approximately 40% of the current patients with clinically diagnosed septicemia had a negative culture. The negative culture could also be a result of sampling error or testing error (false-negative), but this is rare22.  Negative culture results may also reflect issues unique to the microorganism, such as viral or fungal origin, a non-infectious source of symptoms, or genetic differences. Studies have shown that only about 1% of environmental bacteria are currently culturable44,45;  only half of  the bacterial species inhabiting the human mouth have been characterized, and the colonic flora is suspected to be mostly unidentified22. Infection by any of these non-culturable organisms would result in culture negative sepsis. Similar to other studies, as prior antibiotic use was associated with culture negative sepsis, antibiotics may have sterilized the cultures46,47. This shows that pre-sepsis medications might either sterilize the cultures or choose for an infection that isn't culturable. Very low grade toxemia or intermittent bacteremia are other possibilities. Despite these reasons for negative cultures, obtaining cultures is important as, when positive, the sensitivities will affect the class of antibiotic and treatment duration. Considering the prognosis, there was a high rate of positive culture with death (88.1%) with an OR equal to 7.8, CI=2.8–21.5, p<0.001 (Table 3). The present findings on the difference in case-by-case mortality for all sepsis patients differ from several other studies in which there is a similar mortality rate in both diagnostic groups (positive culture vs negative culture). On the other hand, Sigakis et al., found a higher mortality rate in culture-negative patients22

was no significant association with other clinical manifestations (Table 3). This may reflect a higher bacterial load leading to rapid onset of septicemia symptoms. While there was a high rate of positive cultures with decreased urination (68.3%), there was no association between positive blood cultures and other clinical manifestations such as high or low blood pressures, increased heart rate, or increased breathing rate (OR=2.2, CI=1.1-4.3, p=0.02, Table 3).  

Limitations of the study

The limitations of the study were as follows. First, because the data came from one geographical location (Sana’a city), we were not able to accurately determine the types of isolates for Yemen. Secondly, no research was done to identify the sources of infection in this study as Al-Amad et al., have done before48. In determining bacterial contamination of intensive care units. Molecular research should also be conducted on these isolates to confirm the bacterial diagnosis.

 

CONCLUSION

 

BSIs are among the leading causes of infections in ICU patients. Gram-negative bacteria were the most common cause of sepsis, and substantial positive culture results were associated with early onset, decreased urination, older patients, and death. Sepsis's incidence, mortality, and morbidity rates in Yemen are likely underestimated because it is infrequently reported as a primary diagnosis (typically as a consequence of cancer or another illness). More research into the frequency and risk factors of sepsis in ICUs is recommended. The epidemiology of severe sepsis in developing countries may differ significantly from developed countries, warranting greater interest in future studies in developing countries to understand this problem.

 

ACKNOWLEDGEMENTS 

 

Thanks and appreciation to all doctors and health care workers in Kuwait, Al-Jumhuri, Al-Sabeen, and Al-Thawra hospitals in the city of Sana’a for their cooperation and assistance. We also thank Sana’a University for the support.

 

AUTHOR’S CONTRIBUTIONS

 

First author Eshtiaq A. Al-Yousafi did the fieldwork for this study as part of a PhD in the department of Medical Microbiology, Faculty of Medicine and Health Sciences, Sana’a University. Additional authors assisted with data analysis, drafting and reviewing the manuscript, and giving final clearance to the study.

 

 

CONFLICT OF INTEREST 

 

There are no competing interests involved in this work. 

 

REFERENCES

 

  1. Vincent JL, Rello J, Marshall J, et al. EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009 Dec 2; 302(21):2323-9.https://doi.org/10.1001/jama.2009.1754
  1. Rodríguez-Baño J, López-Prieto MD, Portillo MM, et al. Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals. Clin Microbiol Infect 2010 Sep; 16(9):1408-13.https://doi.org/10.1111/j.1469-0691.2009.03089.x
  1. Kollef MH, Zilberberg MD, Shorr AF, et al. Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: A multicenter cohort study. J Infect. 2011 Feb; 62(2):130-5.https://doi.org/10.1016/j.jinf.2010.12.009
  1. Timsit JF, Laupland KB. Update on bloodstream infections in ICUs. CurrOpin Crit Care. 2012 Oct;18(5):479-86.https://doi.org/10.1097/MCC.0b013e328356cefe
  1. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006 Dec 28; 355(26):2725-32. https://doi.org/10.1056/NEJMoa061115
  2. Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004 Oct; 32(10):2014-20.https://doi.org/10.1097/01.ccm.0000142399.70913.2f
  3. Fridkin SK, Pear SM, Williamson TH, Galgiani JN, Jarvis WR. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 1996 Mar; 17(3):150-8.https://doi.org/10.1086/647262
  1. Elemam A, Rahimian J, Mandell W. Infection with panresistant Klebsiella pneumoniae: A report of 2 cases and a brief review of the literature. Clin Infect Dis 2009 Jul 15; 49(2):271-4. https://doi.org/10.1086/600042
  2. Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 2012 Jan; 18(1):54-60.https://doi.org/10.1111/j.1469-0691.2011.03478.x
  1. Johnson MT, Reichley R, Hoppe-Bauer J, Dunne WM, Micek S, Kollef M. Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis. Crit Care Med 2011 Aug; 39(8):1859-65.https://doi.org/10.1097/CCM.0b013e31821b85f4
  1. Sehgal M, Ladd HJ, Totapally B. Trends in Epidemiology and Microbiology of Severe Sepsis and Septic Shock in Children. Hospital Pediatrics 2020; 10 (12): 1021–1030.https://doi.org/10.1542/hpeds.2020-0174 
  1. Tintinalli JE, John Ma O, Yealy DM, et al. (American College of Emergency Physicians). "Ch. 146: Septic Shock. In Tintinalli JE, Stapczynski JS, Ma OJ, Cline DM, Cydulka RK, Meckler GD (eds.). Tintinalli's Emergency Medicine: A Comprehensive Study Guide (7th) 2011; New York: McGraw-Hill. 1003–14. ISBN9780071484800.
  2. Tabah A, Koulenti D, Laupland K, et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med 2012 Dec; 38(12):1930-45. https://doi.org/10.1007/s00134-012-2695-9
  3. Sepsis Questions and Answers". cdc.gov. Centers for Disease Control and Prevention(CDC). 22 May 2014. Archived from the original on 4 December 2014. Retrieved 28 -7- 2023.
  4. Russotto V, Cortegiani A, Graziano G, et al. Bloodstream infections in intensive care unit patients: Distribution and antibiotic resistance of bacteria. Infect Drug Resist 2015 Aug 10; 8:287-96. https://doi.org/10.2147/IDR.S48810
  5. Isenbergh HD. Clinical microbiology procedures handbook. 2nd Washington: ASM Press; 2004.
  6. Peduzzi P, Shatney C, Sheagren J, Sprung C. Predictors of bacteria and gram-negative bacteria in patients with sepsis. The Veterans Affairs Systemic Sepsis Cooperative Study Group. Arch Intern Med 1992 Mar; 152(3):529-35. PMID: 1546915
  7. Yang SC, Liao KM, Chen CW, Lin WC. Positive blood culture is not associated with increased mortality in patients with sepsis-induced acute respiratory distress syndrome. Respirology 2013 Nov; 18(8):1210-6.https://doi.org/10.1111/resp.12121
  1. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006 Jun; 34(6):1589-96.https://doi.org/10.1097/01.CCM.0000217961.75225.E9
  1. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006 Feb; 34(2):344-53.https://doi.org/10.1097/01.ccm.0000194725.48928.3a
  1. Kethireddy S, Bilgili B, Sees A, et al. Cooperative Antimicrobial Therapy of Septic Shock (CATSS) database research group. Culture-negative septic shock compared with culture-positive septic shock: A Retrospective Cohort Study. Crit Care Med. 2018 Apr; 46(4):506-512.https://doi.org/10.1097/CCM.0000000000002924
  1. Sigakis MJG, Jewell E, Maile MD, Cinti SK, Bateman BT. Engoren M. Culture-negative and culture-positive sepsis: A comparison of characteristics and outcomes. Anesth Analg 2019 Nov; 129(5):1300-1309.https://doi.org/10.1213/ANE.0000000000004072
  1. Salah A, Al-Subol I, Hudna A, et al. Neonatal sepsis in Sana'a city, Yemen: A predominance of Burkholderia cepacia. BMC Infect Dis 2021 Oct 27; 21(1):1108.https://doi.org/10.1186/s12879-021-06808-y
  1. Al-Shamahy HA, Sabrah AA, Al-Robasi AB, Naser SM. Types of Bacteria associated with neonatal sepsis in Al-Thawra University Hospital, Sana'a, Yemen, and their antimicrobial profile. Sultan Qaboos Univ Med J 2012 Feb; 12(1):48-54. https://doi.org/10.12816/0003087
  2. Shehab El-Din EM, El-Sokkary MM, Bassiouny MR, Hassan R. Epidemiology of neonatal sepsis and implicated pathogens: A study from Egypt. Biomed Res Int 2015; 2015:509484.https://doi.org/10.1155/2015/509484
  3. Shitaye D, Asrat D, Woldeamanuel Y, Worku B. Risk factors and etiology of neonatal sepsis in Tikur Anbessa University Hospital, Ethiopia. Ethiop Med J 2010 Jan; 48(1):11-21. PMID: 20607993.
  4. Mhada TV, Fredrick F, Matee MI, et al. Neonatal sepsis at Muhimbili National Hospital, Dar es Salaam, Tanzania; aetiology, antimicrobial sensitivity pattern and clinical outcome. BMC Public Health 2012; 12, 904 (2012).https://doi.org/10.1186/1471-2458-12-904
  1. Ansari S, Nepal HP, Gautam R, Shrestha S, Neopane P, Chapagain ML. Neonatal Septicemia in Nepal: Early-Onset versus Late-Onset. Int J Pediatr 2015; 2015:379806.https://doi.org/10.1155/2015/379806
  1. Klingenberg C, Aarag E, Rønnestad A, et al. Coagulase-negative staphylococcal sepsis in neonates. Association between antibiotic resistance, biofilm formation and the host inflammatory response. Pediatr Infect Dis J 2005 Sep; 24(9):817-22.https://doi.org/10.1097/01.inf.0000176735.20008.cd
  1. Lowy F. Staphylococcus aureus N Engl J Med 1998; 339(8): 520–532.https://doi.org/10.1056/NEJM199808203390806
  1. Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009 Sep; 7(9):629-41.https://doi.org/10.1038/nrmicro2200
  1. Kaper J, Nataro J,Mobley H. Pathogenic Escherichia coli. Nat Rev Microbiol 2004; 2, 123–140.https://doi.org/10.1038/nrmicro818
  1. Sawano T, Tsubokura M, Leppold C, et al. Klebsiella pneumoniae sepsis deteriorated by uncontrolled underlying disease in a decontamination worker in Fukushima, Japan. J Occup Health 2016 Jun 16; 58(3):320-2.https://doi.org/10.1539/joh.15-0292-CS
  1. Carmona CA Jr, Marante A, Levent F, Marsicek S. Burkholderia cepaciasepsis in a previously healthy full-term infant. Case Rep Pediatr 2020 Oct 5; 2020:8852847.https://doi.org/10.1155/2020/8852847
  1. Walls S, Adhikari P, Reesha H, Baxter M. Sepsis Due to Haemophilus influenzaeand masked influenza a infection. Cureus 2022 Feb 21; 14(2):e22424.https://doi.org/10.7759/cureus.22424
  1. Sanders WE Jr, Sanders CC. Enterobacter spp.: Pathogens poised to flourish at the turn of the century. Clin Microbiol Rev 1997 Apr; 10(2):220-41.https://doi.org/10.1128/CMR.10.2.220
  1. Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006 Aug 16; 6:130.https://doi.org/10.1186/1471-2334-6-130
  1. Vila J, Martí S, Sánchez-Céspedes J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 2007 Jun; 59(6):1210-5.https://doi.org/10.1093/jac/dkl509
  1. Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 2005 Nov; 11(11):868-73. https://doi.org/10.1111/j.1469-0691.2005.01227.x
  2. Fothergill JL, Winstanley C, James CE. Novel therapeutic strategies to counter Pseudomonas aeruginosa Expert Rev Anti Infect Ther 2012 Feb; 10(2):219-35.https://doi.org/10.1586/eri.11.168.
  1. Adair FW, Geftic SG, Gelzer J. Resistance of Pseudomonas to quaternary ammonium compounds. I. Growth in benzalkonium chloride solution. Appl Microbiol 1969 Sep; 18(3):299-302.https://doi.org/10.1128/am.18.3.299-302.1969
  1. McKew G. Severe sepsis due to Chryseobacterium indologenes in an immunocompetent adventure traveler. J Clin Microbiol 2014 Nov;52(11):4100-1.https://doi.org/10.1128/JCM.01691-14
  1. Sepsis Questions and Answers. cdc.gov. Centers for Disease Control and Prevention(CDC). 22 May 2014. Archived from the original on 4 December 2014. Retrieved 28 November 2014.
  2. Ward DM, Bateson MM, Weller R, Ruff-Roberts AL. Ribosomal analysis of microorganisms as they occur in nature In: Marshall KC (Ed). Advances in Microbial Ecology. New York, Plenum Press 1992; 219–286.
  3. Amann RI, Ludwig W, Schleifer KH. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol Rev 1995 Mar; 59(1):143-69. https://doi.org/10.1128/mr.59.1.143-169.1995
  4. Phua J, Ngerng W, See K, Tay C, et al. Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care 2013 Sep 12; 17(5):R202.https://doi.org/10.1186/cc12896
  1. de Prost N, Razazi K, Brun-Buisson C. Unrevealing culture-negative severe sepsis. Crit Care. 2013 Sep 26; 17(5):1001.https://doi.org/10.1186/cc13022
  1. Al Amad M, Al Shargabi IA, Nasher S, et al. Bacterial Contamination of Intensive Care Units, Sana’a City, Yemen, 2019;iproc 2022; 8(1): e36591.https://doi.org/10.2196/36591